More than Alzheimer’s: AI maps the added burden of Lewy body pathology
One challenge to advancing Alzheimer’s disease treatments is that many patients have mixed brain pathologies, meaning more than one disease process is affecting the brain. This can complicate diagnosis, clinical trial design and treatment development because a therapy targeting only one disease process may be less effective if another is…